Cronos Group Licenses IP From Aurora Cannabis, 22nd Century Group Related To Biosynthesis

Aurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ: XXII) and Cronos Group (TSX: CRON). The arrangement will see the licensing of certain IP related to biosynthesis to that of Cronos.

The licensing deal is said to assist in the advance of R&D for the biosynthesis of certain cannabinoids. The IP is currently held in jointly between 22nd Century Group and Aurora Cannabis, with the intellectual property originating from early work conducted by a former Chief Science Officer of Aurora, which pertains to the discovery of key genes in the cannabinoid biosynthesis pathway.

With Aurora and 22nd Century sharing the global IP rights for the commercialization of what are deemed to be “key aspects of cannabinoid biosynthesis in plants and micro-organisms,” Cronos was effectively required to go through them in order to commercialize the biosynthesis of certain compounds from the plant. The duo note that they are “working closely to enforce their IP against infringing parties,” suggesting that they strong armed Cronos into such a licensing arrangement.

Cronos for their part commented that the IP “provides [them] with a component of the process that could allow for increased speed and efficiency in the development and commercialization of cultured cannabinoids.”

Financial aspects of the licensing deal were not provided by the company.

Cronos Group last traded at $5.23 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization unless otherwise mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

SSR Mining Q1 Earnings: Costs Continue To Climb

Recommended

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

First Majestic Makes Second Major Discovery At Santa Elena In Just A Year

Related News

Aurora Cannabis: Canaccord Anticipates Q2 Revenues Of $69.5 Million

On Thursday, February 11th, Aurora Cannabis (TSX: ACB) (NYSE: ACB) is scheduled to release their...

Tuesday, February 9, 2021, 04:01:00 PM

Aurora Cannabis Increases Offering To US$150 Million

It appears that Aurora Cannabis (TSX: ACB) (NYSE: ACB) has been somewhat successful in its...

Wednesday, November 11, 2020, 09:47:36 AM

Aurora Cannabis Acquires Undisclosed Stake In Dutch Cannabis Firm, Zero Details Provided

With its Canadian market share falling apart, Aurora Cannabis (TSX: ACB) has evidently placed its...

Monday, November 8, 2021, 08:42:23 AM

Aurora Cannabis Posts Loss of $158 Million for Third Quarter

Aurora Cannabis (TSX: ACB; NYSE: ACB) reported its third quarter 2019 earnings last night, posting...

Wednesday, May 15, 2019, 07:00:27 AM

Cronos Group Subject Of SEC Inquiry

This evening, MarketWatch reporter Max Cherney broke the story that Cronos Group (TSX: CRON) (NASDAQ:...

Thursday, March 19, 2020, 09:59:02 PM